Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|80|5-6|341-349

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.5-6, 2011-07, pp. : 341-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Basis of Distant Medulloblastoma Recurrence

By  

Pediatric Neurosurgery, Vol. 52, Iss. 3, 2017-03 ,pp. : 217-217

Karger

Access to resources Recommend Favorite

Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence‐free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy

By  

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4231-4241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 324-330

Karger

Access to resources Recommend Favorite

Advances in the adjuvant and neoadjuvant treatment of breast cancer

By Briest Susanne   Stearns Vered  

Women's Health, Vol. 3, Iss. 3, 2007-05 ,pp. : 325-339

Future Medicine

Access to resources Recommend Favorite

Predictive Factors for Response to Neoadjuvant Therapy in Breast Cancer

By  

Oncology Research and Treatment, Vol. 37, Iss. 10, 2014-09 ,pp. : 563-568

Karger

Access to resources Recommend Favorite